The Transcatheter Tricuspid Valve Replacement market expands as Laplace launches its 400-patient pivotal study.
Edwards Lifesciences secures FDA clearance for its ECLIPTIS Left Atrial Appendage Exclusion System, entering a competitive ...
SBIR program renewed, but NIH's strict security rules may hurt medtech funding. President Trump signed S. 3971 on April 13, ...
MD+DI Senior Editor Amanda Pedersen takes a close look at the trend of partnerships and collaborations in the medical device ...
Gainline Capital Partners said its portfolio company M&M International has acquired KC Tech, a strategic partner and fellow ...
Medline recalls over 7,000 cardiac procedure kits due to contaminated anesthetic injections.The recall is the latest in a ...
Edwards TAVR data has a strong showing at NY Valves 2026 amid intense industry competition from Abbott Laboratories and Medtronic.
Medtech companies are often evaluated through a narrow lens: the technology, the IP, the regulatory pathway, and the size of the market. All of that matters, but it leaves out one of the biggest ...
Research shows a new procedure, genicular artery embolization (GAE) could provide a viable alternative to knee replacement ...
On June 8, at the American Diabetes Association meeting, Adaptyx Biosciences put up data the field has chased for ten years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results